These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 18457928

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM, Li YJ, Qiu LY, Jin Y.
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [Abstract] [Full Text] [Related]

  • 23. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
    Mi FL, Wu YY, Chiu YL, Chen MC, Sung HW, Yu SH, Shyu SS, Huang MF.
    Biomacromolecules; 2007 Mar; 8(3):892-8. PubMed ID: 17316043
    [Abstract] [Full Text] [Related]

  • 24. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes.
    Mao SJ, Hou SX, He R, Zhang LK, Wei DP, Bi YQ, Jin H.
    World J Gastroenterol; 2005 May 28; 11(20):3075-9. PubMed ID: 15918193
    [Abstract] [Full Text] [Related]

  • 25. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
    Contreras-Ruiz L, de la Fuente M, García-Vázquez C, Sáez V, Seijo B, Alonso MJ, Calonge M, Diebold Y.
    Cornea; 2010 May 28; 29(5):550-8. PubMed ID: 20335805
    [Abstract] [Full Text] [Related]

  • 26. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.
    Özbaş-Turan S, Akbuğa J.
    Drug Deliv; 2011 Apr 28; 18(3):215-22. PubMed ID: 21226549
    [Abstract] [Full Text] [Related]

  • 27. Transmucosal macromolecular drug delivery.
    Prego C, García M, Torres D, Alonso MJ.
    J Control Release; 2005 Jan 03; 101(1-3):151-62. PubMed ID: 15588901
    [Abstract] [Full Text] [Related]

  • 28. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 29. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q, Wang T, Cochrane C, McCarron P.
    Colloids Surf B Biointerfaces; 2005 Aug 01; 44(2-3):65-73. PubMed ID: 16024239
    [Abstract] [Full Text] [Related]

  • 30. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan.
    Sheng Y, Liu C, Yuan Y, Tao X, Yang F, Shan X, Zhou H, Xu F.
    Biomaterials; 2009 Apr 01; 30(12):2340-8. PubMed ID: 19150737
    [Abstract] [Full Text] [Related]

  • 31. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK, Cheng KM, Hu CS, Huang YC, Young JJ.
    Acta Biomater; 2011 Oct 01; 7(10):3804-12. PubMed ID: 21742066
    [Abstract] [Full Text] [Related]

  • 32. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H, Oh M, Allen C, Kumacheva E.
    Biomacromolecules; 2004 Oct 01; 5(6):2461-8. PubMed ID: 15530064
    [Abstract] [Full Text] [Related]

  • 33. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R, Paliwal SR, Agrawal GP, Vyas SP.
    Int J Pharm; 2012 Jan 17; 422(1-2):179-84. PubMed ID: 22079712
    [Abstract] [Full Text] [Related]

  • 34. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, Kim SY, Cho YW.
    J Control Release; 2006 Sep 28; 115(1):37-45. PubMed ID: 16935380
    [Abstract] [Full Text] [Related]

  • 35. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J, Chen XG, Peng WB, Liu CS.
    Nanomedicine; 2008 Sep 28; 4(3):208-14. PubMed ID: 18508414
    [Abstract] [Full Text] [Related]

  • 36. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 28; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 37. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
    Nam HY, Kwon SM, Chung H, Lee SY, Kwon SH, Jeon H, Kim Y, Park JH, Kim J, Her S, Oh YK, Kwon IC, Kim K, Jeong SY.
    J Control Release; 2009 May 05; 135(3):259-67. PubMed ID: 19331853
    [Abstract] [Full Text] [Related]

  • 38. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B, Pan C, Sun Y, Hou Z, Ye H, Zeng X.
    J Agric Food Chem; 2008 Aug 27; 56(16):7451-8. PubMed ID: 18627163
    [Abstract] [Full Text] [Related]

  • 39. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
    Teijeiro-Osorio D, Remuñán-López C, Alonso MJ.
    Eur J Pharm Biopharm; 2009 Feb 27; 71(2):257-63. PubMed ID: 18955137
    [Abstract] [Full Text] [Related]

  • 40. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
    Trapani A, Lopedota A, Franco M, Cioffi N, Ieva E, Garcia-Fuentes M, Alonso MJ.
    Eur J Pharm Biopharm; 2010 May 27; 75(1):26-32. PubMed ID: 20102738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.